Sales & Marketing Views & Analysis

Views & Analysis

Sales & Marketing

J&J tops the pharma market cap charts – but for how long?

Data and analytics firm GlobalData has tracked the market cap and performance of the top 25 pharma companies for the first quarter of this year – and there are some notable changes compared

Views & Analysis

Anthill Andre Hansen, Lions Health 2018 jury member

Was pharma bold enough at Lions Health 2018?

The Lions Health 2018 jury brought 10 senior communications executives together in Cannes, with representatives from China, Australia, UK, US, Brazil, Dubai, Ireland and Denmark.

Views & Analysis

How to achieve digital success in pharma’s communications

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for pharma communications according to Katrine Bach, the CEO of&

Views & Analysis

3d rendering robot working with digital display

Future-proofing pharma with a multichannel approach to sales...

Deploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and secure a successful future, but remaining inactive in this area would be a

Views & Analysis

How the EU’s GDPR will be a positive catalyst for change

Now that the GDPR deadline of May 25 has come and gone, many life sciences companies will have come to realise that GDPR compliance is not simply a legal problem or an IT project, but an enterprise

Views & Analysis

Top pharmaceutical companies in the world in 2017

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.

J&J tops the pharma market cap charts – but for how long?

Was pharma bold enough at Lions Health 2018?

How to achieve digital success in pharma’s communications

Future-proofing pharma with a multichannel approach to sales...

How the EU’s GDPR will be a positive catalyst for change

Top pharmaceutical companies in the world in 2017

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks